Latest Global Markets News

Clover Corporation posted a robust 38% revenue increase to $86 million in FY25, driven by product innovation and operational gains, while declaring a final dividend. The company’s cautious outlook for FY26 reflects ongoing regulatory and production challenges.

EVE Health Group has begun distributing Dyspro™, a novel cannabinoid-based treatment for dysmenorrhoea and endometriosis, through a national telehealth partnership. This launch targets a significant unmet need in women’s health with a growing global market.

Resimac Group has successfully settled a A$1 billion non-conforming residential mortgage backed securities transaction, marking its second such bond issuance this year. The deal attracted strong domestic and offshore investor interest, reinforcing Resimac’s diversified funding strategy.

Pathkey.AI has upgraded its TrialKey platform to include drug-level molecular and pharmacokinetic features, enhancing clinical trial predictions and opening doors to AI-driven drug discovery.

Coppermoly Limited has secured 100% ownership of the Wyemandoo Project in Western Australia, gaining exposure to key critical minerals amid rising global demand.

Fat Prophets Global Contrarian Fund has successfully closed its Share Purchase Plan, raising nearly $1 million from existing shareholders. The capital injection will see over 740,000 new shares issued at a modest discount.

Sunrise Energy Metals has attracted a significant financing interest from the U.S. Export-Import Bank, potentially securing half the capital needed for its Syerston Scandium Project amid shifting global supply dynamics.

Magellan Asset Management has announced a special distribution of 11.00 cents per unit for its Magellan Global Opportunities Fund – Active ETF, offering investors a timely income boost alongside a reinvestment option.

EVE Health Group has appointed Dr Fiona Cousins as the inaugural member of its Scientific Advisory Board, reinforcing its commitment to advancing treatments for dysmenorrhoea and endometriosis ahead of the commercial launch of Dyspro™.

TZ Limited appoints Antonino Schiavello as Non-Executive Director and partners with his Nura Space venture to accelerate workplace technology solutions, while securing a $750,000 credit extension to support product delivery.

Adelong Gold has locked in a $1.25 million strategic investment from Nova Minerals and Barclay Wells clients, enabling accelerated exploration at its NSW and Victorian gold and antimony projects. This partnership includes board representation and offtake rights, positioning Adelong for growth in proven mineral corridors.

Trading in Jindalee Lithium Limited shares has resumed following the company’s announcement of a potential merger, signaling a pivotal moment for the lithium miner.